PACB
Pacific Biosciences of California
2.50$
+1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +53.1% | -2.2% | +3.0% | -15.9% | +15.6% | -13.2% | +65.4% | -1.7% | +56.3% | -23.2% | +3.9% | |
| – | +5.8% | +18.4% | +26.3% | -9.0% | +5.2% | -17.7% | +54.7% | +10.6% | +86.4% | -21.0% | -6.3% | |
| – | +128.4% | -17.4% | -21.5% | -27.6% | +37.8% | -5.8% | +80.7% | -16.7% | +7.6% | -29.4% | +35.9% | |
| – | +25.3% | +11.9% | -3.4% | -4.2% | -4.7% | +7.6% | +76.0% | +70.9% | -3.0% | -27.9% | -27.9% | |
| – | +18.8% | +5.8% | +23.7% | +7.4% | +18.9% | -3.6% | +70.5% | +29.6% | +5.0% | +3.7% | -19.2% | |
| – | +22.5% | +9.3% | +7.8% | +1.3% | +7.2% | +1.4% | +96.6% | +32.3% | +8.7% | +32.1% | +18.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.5% | +10.5% | -9.7% | -17.0% | +7.8% | -89.8% | +4,592.9% | +17.2% | -2.4% | -6.5% | -48.2% | |
| – | – | – | – | – | – | – | -1,034.8% | – | – | – | – | |
| – | -116.5% | – | -250.0% | – | -844.7% | – | – | – | – | – | +0.6% | |
| – | – | – | – | – | – | – | -716.3% | – | – | – | – | |
| – | – | – | – | – | – | – | -743.4% | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.